Fermentation capacity of gut microbiota in patients with inflammatory bowel disease compared to healthy controls

被引：0
|
作者：
McGowan, M. [1 ]
Kokkorou, M. [1 ]
Rebull, M. [1 ]
Koh, Y. [2 ]
Gaya, D. R. [3 ]
Hansen, R. [4 ]
Russell, R. K. [4 ]
Gerasimidis, K. [1 ]
机构：
[1] Univ Glasgow, Human Nutr, Glasgow, Lanark, Scotland
[2] Univ Glasgow, Glasgow, Lanark, Scotland
[3] Glasgow Royal Infirm, Gastroenterol Unit, Glasgow, Lanark, Scotland
[4] Royal Hosp Children Glasgow, Paediat Gastroenterol, Glasgow, Lanark, Scotland
来源：
JOURNAL OF CROHNS & COLITIS | 2017年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P587
引用
收藏
页码：S379 / S380
页数：2
相关论文
共 50 条
  • [1] FERMENTATION CAPACITY OF GUT MICROBIOTA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE COMPARED TO HEALTHY CONTROLS
    Kokkorou, M.
    McGowan, M.
    Rebull, M.
    Koh, Y.
    Gaya, D. R.
    Hansen, R.
    Russell, R. K.
    Gerasimidis, K.
    [J]. GUT, 2017, 66 : A237 - A237
  • [2] Characterization of the gut microbiota in patients with primary sclerosing cholangitis compared to inflammatory bowel disease and healthy controls
    Ostadmohammadi, Samaneh
    Azimirad, Masoumeh
    Houri, Hamidreza
    Naseri, Kaveh
    Javanmard, Ehsan
    Mirjalali, Hamed
    Yadegar, Abbas
    Sadeghi, Amir
    Asadzadeh Aghdaei, Hamid
    Zali, Mohammad Reza
    [J]. MOLECULAR BIOLOGY REPORTS, 2021, 48 (07) : 5519 - 5529
  • [3] Characterization of the gut microbiota in patients with primary sclerosing cholangitis compared to inflammatory bowel disease and healthy controls
    Samaneh Ostadmohammadi
    Masoumeh Azimirad
    Hamidreza Houri
    Kaveh Naseri
    Ehsan Javanmard
    Hamed Mirjalali
    Abbas Yadegar
    Amir Sadeghi
    Hamid Asadzadeh Aghdaei
    Mohammad Reza Zali
    [J]. Molecular Biology Reports, 2021, 48 : 5519 - 5529
  • [4] Effects of bowel cleansing on the composition of the gut microbiota in inflammatory bowel disease patients and healthy controls
    Bacsur, Peter
    Rutka, Mariann
    Asboth, Andras
    Resal, Tamas
    Szanto, Kata
    Jojart, Boldizsar
    Balint, Anita
    Ari, Eszter
    Ajibola, Walliyulahi
    Kintses, Balint
    Feher, Tamas
    Pigniczki, Daniella
    Bor, Renata
    Fabian, Anna
    Maleth, Jozsef
    Szepes, Zoltan
    Farkas, Klaudia
    Molnar, Tamas
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
  • [5] Hepcidin levels in inflammatory bowel disease compared with healthy controls
    Busbridge, M.
    Arnold, J.
    Sangwaiya, A.
    Chapman, R.
    [J]. CLINICAL CHEMISTRY, 2009, 55 (06) : A169 - A169
  • [6] Importance of Gut Microbiota in Patients with Inflammatory Bowel Disease
    Ekstedt, Natalia
    Jamiol-Milc, Dominika
    Pieczynska, Joanna
    [J]. NUTRIENTS, 2024, 16 (13)
  • [7] Gut Microbiota Dysbiosis in Patients with Intracerebral Hemorrhage Compared with Healthy Controls
    Ai, Tianyi
    Zhang, Zhiyun
    Zhu, Mingli
    Wang, Lihui
    Wu, Hui
    Tang, Jiajia
    Shi, An
    Shi, Zhiqiang
    Li, Min
    Li, Hui
    [J]. JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (05): : 2809 - 2817
  • [8] The gut microbiota and inflammatory bowel disease
    Katsuyoshi Matsuoka
    Takanori Kanai
    [J]. Seminars in Immunopathology, 2015, 37 : 47 - 55
  • [9] The Gut Microbiota in Inflammatory Bowel Disease
    Macfarlane, G. T.
    Blackett, K. L.
    Nakayama, T.
    Steed, H.
    Macfarlane, S.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (13) : 1528 - 1536
  • [10] The gut microbiota and inflammatory bowel disease
    Matsuoka, Katsuyoshi
    Kanai, Takanori
    [J]. SEMINARS IN IMMUNOPATHOLOGY, 2015, 37 (01) : 47 - 55
12345